Collegium Pharma (COLL) Stock Price, Quote & News

Company Profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-dete...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 713 3699

Website: www.collegiumpharma.com

Address:

100 Technology Center Drive, Suite 300, Stoughton, United States

jewell69 Apr. 22 at 6:42 PM

in grandpa's acct, lots of red ink on $COLL he needs to wait another 28 days before the wash rule expires, ugh ! 04/20/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 100 $35.27 $0.09 $3,526.91 More 02/26/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 80 $44.22 -$3,537.60 More 02/23/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 20 $44.30 -$886.00 More 01/09/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 40 $46.04 $0.01 $1,841.59 More 01/09/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 40 $45.29 -$1,811.60 More Total $0.10 -$866.70 real money losses here, people

0 · Reply

jewell69 Apr. 22 at 6:40 PM

$COLL trade history looks pretty good IN THIS ACCT (but) 04/22/2026 Sell Edit cost basis method CRCL CIRCLE INTERNET GROUP INCLASS CLASS A 36 $102.115 $0.09 $3,676.05 More 04/21/2026 Buy CRCL CIRCLE INTERNET GROUP INCLASS CLASS A 36 $100.10 -$3,603.60

0 · Reply

jewell69 Apr. 22 at 6:40 PM

ANOTHER CIRCLE $CRCL DAY TRADE, COUPLED WITH A $COLL RE-ENTRY (I finally caught on to just trade coll in the 33's and 34's and just take my losses in grandpa's account where he bought a few shares in the 44's ! )

0 · Reply

tilance Apr. 22 at 3:17 PM

$COLL opened a position here today...

0 · Reply

topstockalerts Apr. 22 at 12:19 PM

Morning Movers 🌞 $COLL $ELPW $HCAI $KBSX $POET

0 · Reply

Astrid00 Apr. 22 at 11:52 AM

$COLL $ELPW $HCAI $KBSX $KYTX

0 · Reply

topstockalerts Apr. 22 at 11:52 AM

Pre Market Top Gainers $HCAI $ELPW $COLL $KBSX $KYTX

0 · Reply

topstockalerts Apr. 22 at 11:00 AM

Pre Market Top Gainers $HCAI $ELPW $COLL $KBSX $KYTX

0 · Reply

jewell69 Apr. 21 at 4:50 PM

small trades today in Sis' account b 10 $QURE 17.14 b 30 $COLL 33.77 b 36 $CRCL 100.10

0 · Reply

jewell69 Apr. 20 at 10:26 PM

$KRE s 4/20 70.93 b 3/10 66.10 divvy 109.28 3/25 on 300 4/20 b $ILF 37.725 (long time, no see ) 4/20 s 100 $COLL 35.27 at a loss 4/20 $FRDM b 62.68 oops s in the 61's last week 1st trade day trade s 35 102.98 b 35 102.12 $CRCL 4/20 close 106.36 As Arsenio Hall would always would say: "things that make you say hmmmm "

0 · Reply

Collegium to Report First Quarter 2026 Financial Results on May 7, 2026

Apr 15, 2026, 2:15 PM EDT - 10 days ago

Collegium Pharmaceutical Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 8:00 AM EDT - 17 days ago

Collegium to Participate in Upcoming Investor Conferences

Mar 19, 2026, 9:00 AM EDT - 5 weeks ago

Collegium Pharmaceutical Transcript: M&A announcement

Mar 19, 2026, 8:00 AM EDT - 5 weeks ago

Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

Mar 11, 2026, 9:00 AM EDT - 6 weeks ago

Collegium Pharmaceutical Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 5, 2026, 8:00 AM EST - 7 weeks ago

Collegium to Present New Real-World Data at PainConnect 2026

Feb 26, 2026, 8:00 AM EST - 2 months ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2025

Feb 26, 2026, 7:30 AM EST - 2 months ago

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

Jan 15, 2026, 8:00 AM EST - 3 months ago

Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

Jan 8, 2026, 8:00 AM EST - 3 months ago

Collegium Provides 2026 Financial Guidance and Business Update

Dec 30, 2025, 8:00 AM EST - 4 months ago

Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Dec 2, 2025, 2:30 PM EST - 5 months ago

Collegium Pharmaceutical Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 3:00 AM EST - 5 months ago

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2025

Nov 6, 2025, 7:30 AM EST - 6 months ago

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance

Oct 30, 2025, 5:15 PM EDT - 6 months ago

Knight Therapeutics Announces Launch of JORNAY PM™ in Canada

Oct 23, 2025, 8:00 AM EDT - 6 months ago

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 22, 2025, 8:00 AM EDT - 6 months ago

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

Oct 13, 2025, 8:00 AM EDT - 6 months ago

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

Sep 9, 2025, 10:30 AM EDT - 8 months ago

Collegium Pharmaceutical Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 2:35 PM EDT - 8 months ago

Collegium Pharmaceutical Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 25, 2025, 8:00 AM EDT - 8 months ago

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

Aug 7, 2025, 8:00 AM EDT - 9 months ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 9 months ago

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook

Jul 24, 2025, 8:00 AM EDT - 9 months ago

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 7, 2025, 8:00 AM EDT - 10 months ago

Collegium Announces $150 Million Share Repurchase Program

Jun 5, 2025, 1:25 PM EDT - 11 months ago

Collegium Pharmaceutical Transcript: Jefferies Global Healthcare Conference 2025

May 12, 2025, 8:05 AM EDT - 1 year ago

Collegium Announces $25 Million Accelerated Share Repurchase Program

May 8, 2025, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:01 PM EDT - 1 year ago

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 8, 2025, 9:30 AM EDT - 1 year ago

Collegium Pharmaceutical Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Mar 17, 2025, 7:00 AM EDT - 1 year ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Mar 10, 2025, 6:57 PM EDT - 1 year ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Feb 27, 2025, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:01 PM EST - 1 year ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 8:00 AM EST - 1 year ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Jan 8, 2025, 8:00 AM EST - 1 year ago

Collegium Provides 2025 Financial Guidance and Business Update

Dec 5, 2024, 1:00 PM EST - 1 year ago

Collegium Pharmaceutical Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 8:30 AM EST - 1 year ago

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Nov 7, 2024, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:02 PM EST - 1 year ago

Collegium Reports Record Third Quarter 2024 Financial Results

Sep 9, 2024, 12:30 PM EDT - 1 year ago

Collegium Pharmaceutical Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 30, 2024, 8:00 AM EDT - 1 year ago

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Collegium Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 8:30 AM EDT - 1 year ago

Collegium Pharmaceutical Transcript: M&A Announcement

Jul 29, 2024, 6:00 AM EDT - 1 year ago

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

Jun 5, 2024, 9:30 AM EDT - 2 years ago

Collegium Pharmaceutical Transcript: Jefferies 2024 Global Healthcare Conference

May 29, 2024, 8:00 AM EDT - 2 years ago

Collegium to Participate in Jefferies Global Healthcare Conference

May 13, 2024, 8:00 AM EDT - 2 years ago

Collegium Announces $35 Million Accelerated Share Repurchase Program

May 9, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q1 2024

May 9, 2024, 4:02 PM EDT - 2 years ago

Collegium Reports First Quarter 2024 Financial Results

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 11, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Apr 10, 2024, 3:45 PM EDT - 2 years ago

Collegium Pharmaceutical Transcript: 23rd Annual Needham Virtual Healthcare Conference

Feb 22, 2024, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2023

Feb 22, 2024, 4:09 PM EST - 2 years ago

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

Feb 8, 2024, 8:00 AM EST - 2 years ago

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Nov 28, 2023, 4:00 PM EST - 2 years ago

Collegium Pharmaceutical Transcript: The Piper Sandler 35th Annual Healthcare Conference

Nov 27, 2023, 8:00 AM EST - 2 years ago

Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent

Nov 14, 2023, 4:30 AM EST - 2 years ago

Collegium Pharmaceutical Transcript: 14th Annual Jefferies London Healthcare Conference 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2023

Nov 7, 2023, 4:01 PM EST - 2 years ago

Collegium Reports Third Quarter 2023 Financial Results

Oct 24, 2023, 8:00 AM EDT - 2 years ago

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

Aug 28, 2023, 8:00 AM EDT - 2 years ago

Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

Aug 24, 2023, 8:00 AM EDT - 2 years ago

Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026

Aug 7, 2023, 7:30 AM EDT - 2 years ago

Collegium Announces $50 Million Accelerated Share Repurchase Program

Aug 3, 2023, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2023

Aug 3, 2023, 4:01 PM EDT - 2 years ago

Collegium Reports Record 1H'23 Net Revenue of $280.3 Million, Up 35% Year-over-Year

Jul 20, 2023, 8:00 AM EDT - 3 years ago

Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023

Jun 1, 2023, 8:00 AM EDT - 3 years ago

Collegium to Participate in Jefferies Healthcare Conference

May 4, 2023, 4:30 PM EDT - 3 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q1 2023

May 4, 2023, 4:01 PM EDT - 3 years ago

Collegium Reports First Quarter 2023 Financial Results

Apr 20, 2023, 8:00 AM EDT - 3 years ago

Collegium to Report First Quarter 2023 Financial Results on May 4, 2023

Feb 23, 2023, 4:30 PM EST - 3 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2022

Nov 3, 2022, 7:45 AM EDT - 3 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2022

Aug 4, 2022, 4:30 PM EDT - 4 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2022

jewell69 Apr. 22 at 6:42 PM

0 · Reply

jewell69 Apr. 22 at 6:40 PM

0 · Reply

jewell69 Apr. 22 at 6:40 PM

0 · Reply

tilance Apr. 22 at 3:17 PM

$COLL opened a position here today...

0 · Reply

topstockalerts Apr. 22 at 12:19 PM

Morning Movers 🌞 $COLL $ELPW $HCAI $KBSX $POET

0 · Reply

Astrid00 Apr. 22 at 11:52 AM

$COLL $ELPW $HCAI $KBSX $KYTX

0 · Reply

topstockalerts Apr. 22 at 11:52 AM

Pre Market Top Gainers $HCAI $ELPW $COLL $KBSX $KYTX

0 · Reply

topstockalerts Apr. 22 at 11:00 AM

Pre Market Top Gainers $HCAI $ELPW $COLL $KBSX $KYTX

0 · Reply

jewell69 Apr. 21 at 4:50 PM

small trades today in Sis' account b 10 $QURE 17.14 b 30 $COLL 33.77 b 36 $CRCL 100.10

0 · Reply

jewell69 Apr. 20 at 10:26 PM

0 · Reply

jewell69 Apr. 20 at 2:04 PM

$COLL b 75 32.99 4/16 s 25 33.89 4/17 s 25 4/20 34.71 s 25 4/20 34.73 however, this MASKS THE 20 I B 2/23 44.30 and the 80 I b at 44.22 on 2/26

0 · Reply

jewell69 Apr. 16 at 4:47 PM

ok ok so I'm down in $COLL (during this iteration ) b 20 44.30 2/23 b 80 44.82 2/26 right f. now 33.14 at 12:41 pm est. trying to buy at 32.99 now b a 33.03 x .19 Got Opium ? non-addictive pain medicine is their forte, plus they are just now (3/10) entering another big area. I forgot what it is.

0 · Reply

WallStreetBuyDip Apr. 13 at 3:14 AM

my strategy is patience. waiting for $COLL H% to be low like shown here

0 · Reply

MikeCaymanTrades Apr. 12 at 11:16 PM

$COLL- Signal Update Today's recommendation from our system is to STAY LONG. The previous BUY signal was issued on 04/07/2026, 3 days ago, when the stock price was 32.76. Since then, COLL has risen by +8.27%.

0 · Reply

Estimize Apr. 8 at 1:03 PM

Wall St is expecting 1.81 EPS for $COLL Q1 [Reporting 05/07 AMC] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co

0 · Reply

jewell69 Mar. 28 at 12:05 AM

Friday 3/27 buys. Travel day; I could barely get these done Add on b 8 $COLL 259.52 they are entering ADHD market; usual claim to fame: non-addictive pain medicine $IWM b a tonic it 242.71 I held my nose and b more $ONDS Military drones 500 at 8.77

0 · Reply

Binsie Mar. 24 at 11:07 PM

$COLL on radar. Very oversold. Good underlying results and interesting market focus area. WDYT? Missing something?

0 · Reply

LibertarianTreehugger Mar. 22 at 11:07 PM

This Isn’t a Breakthrough ADHD Drug, But It’s Still Quite Valuable: https://jlsfund.substack.com/p/this-isnt-a-breakthrough-adhd-drug $COLL

0 · Reply

Trend123 Mar. 17 at 1:13 PM

$ZVRA $COLL bought jornay ( a sub Azstarys without the the SDX possibilities ) for 500M$ when Neil was working there .

1 · Reply

jewell69 Mar. 6 at 7:39 PM

$BEAM day trade 3/6 03/06/2026 Sell Edit cost basis method BEAM BEAM THERAPEUTICS INC 50 $26.7234 $0.01 $1,336.16 More 03/06/2026 Buy BEAM BEAM THERAPEUTICS INC 50 $26.30 -$1,315.00 More Total $0.01 $21.16 bottom line profit we will be selling $ADBE and $COLL on a mkt on close basis (just 50 shares each; day trading with an eye dropper )

0 · Reply

jewell69 Mar. 6 at 5:43 PM

buying on the dip with an eye dropper 03/06/2026 Buy ADBE ADOBE INC 6 $278.88 -$1,673.28 More 03/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 50 $36.74 -$1,837.00 More 03/06/2026 Buy BEAM BEAM THERAPEUTICS INC 50 $26.30 -$1,315.00 $ADBE $COLL $BEAM fwiw I didn't buy $CDNS at 297.xx new topic: 2 days ago Iran missle launches down 73% today 3/6/26 Iran missle launches down 90%

0 · Reply

Tfizzle Mar. 6 at 12:35 PM

$COLL gap down. Gap N Go? Rsi too low to ignore

0 · Reply

Market Cap	1.05B
Revenue (ttm)	780.57M
Net Income (ttm)	62.87M
EPS (ttm)	N/A
PE Ratio	5.00
Forward PE	5.08
Profit Margin	8.05%
Debt to Equity Ratio	1.89

Volume	373,100
Avg Vol	538,076
Day's Range	N/A - N/A
Shares Out	32.41M
Stochastic %K	14%
Beta	0.77
Analysts	Strong Sell
Price Target	$54.17